KEYNA MARTINEZ: Open Payments
NPI 1013941699 · BREMEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 57 payments from 19 companies in 2025. Trend: 2023 $739 · 2024 $894 · 2025 $1,072
Food & beverage: $1,052Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $271 |
| ABBVIE INC. | 8 | $137 |
| Novo Nordisk Inc | 4 | $82 |
| PFIZER INC. | 5 | $78 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $51 |
| Lilly USA, LLC | 3 | $50 |
| Abbott Laboratories | 2 | $30 |
Products named: FARXIGA, VRAYLAR, AIRSUPRA, NURTEC ODT, Auvelity, Kerendia, BREZTRI, JARDIANCE.
Industry payments across IN — which companies pay providers there.
